- Innovative biomolecule copying technology
- Effective identification of vaccine precursors within 48 h
- Portfolio of 12 patents for 40 applications
We are looking for investors
At BioCopy, we have developed a new technology that fights diseases and boosts various markets.
Strong reasons to trust in BioCopy:
- Spin-off from the University of Freiburg
- Public funding of 3.3 million € (until the end of 2019)
- Multi award-winning interdisciplinary team